Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome
Top Cited Papers
Open Access
- 1 October 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Brain
- Vol. 126 (10), 2279-2290
- https://doi.org/10.1093/brain/awg233
Abstract
Bickerstaff reported eight patients who, in addition to acute ophthalmoplegia and ataxia, showed drowsiness, extensor plantar responses or hemisensory loss. This condition has been named Bickerstaff’s brainstem encephalitis (BBE). One patient had gross flaccid weakness in the four limbs. Presumably because of the rarity of this disorder, there has been no reported study on a large number of patients with BBE. To clarify its clinical features, we reviewed detailed clinical profiles and laboratory findings for 62 cases of BBE diagnosed by the strict criteria of progressive, relatively symmetrical external ophthalmoplegia and ataxia by 4 weeks, and disturbance of consciousness or hyperreflexia. Ninety‐two per cent of the patients involved had had an antecedent illness. Besides ophthalmoplegia and ataxia, disturbance of consciousness was frequent (74%), and facial diplegia (45%), Babinski’s sign (40%) and pupillary abnormality and bulbar palsy (34%) were present. Almost all the patients had a monophasic remitting course and generally a good outcome. Serum anti‐GQ1b IgG antibody was positive in 66%, and MRI showed brain abnormality in 30% of the patients. Another striking feature was the association with flaccid symmetrical tetraparesis, seen in 60% of the patients. An autopsy study of a BBE patient clearly showed the presence of definite inflammatory changes in the brainstem: there was perivascular lymphocytic infiltration with oedema and glial nodules. Electrodiagnostic study results suggested peripheal motor axonal degeneration. Limb weakness in the BBE cases studied was considered the result of overlap with the axonal subtype of Guillain–Barré syndrome. These findings confirm that BBE constitutes a clinical entity and provide additional clinical and laboratory feaures of BBE. A considerable number of BBE patients have associated axonal Guillain–Barré syndrome, indicative that the two disorders are closely related and form a continuous spectrum.Keywords
This publication has 40 references indexed in Scilit:
- Erratum to “T.O.1 Randomized trial on the additional effect of methylprednisolone on standard treatment with intravenous immunoglobulin in Guillain-Barré syndrome” [Neuromuscul Disord 12 (2002) 781]Neuromuscular Disorders, 2002
- Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 gangliosideAnnals of Neurology, 2001
- N‐glycolylneuraminic acid–containing GM1 is a new molecule for serum antibody in Guillain‐Barré syndromeAnnals of Neurology, 1998
- Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain–Barré and Fisher's syndromesJournal of Neuroimmunology, 1998
- Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodiesBrain, 1995
- Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Guillain-Barré syndrome mistaken for brain stem deathPublished by Oxford University Press (OUP) ,1991
- Guillain–Barré syndrome mimicking brainstem deathAnaesthesia, 1990
- The nosological position of the ophthalmoplegia, ataxia and areflexia syndrome: “The spectrum hypothesis”Acta Neurologica Scandinavica, 1987
- Brain-stem EncephalitisBMJ, 1957